The University of Helsinki has nominated Professor
“This is a fantastic opportunity to combine cutting edge translational cancer research and the unique digital health resources and registries. The ambition level is high, and requires efficient integration of our strengths and engagement of companies. There is a lot of excitement; now iCAN needs to provide clear engagement opportunities,” notes Mäkelä.
“The research will initiate with setting up the Digital Precision Cancer Medicine technology platform and piloting the concept in selected cancer types.”
“We are very happy to have Tomi join iCAN full time,” notes Scientific Director, Academy Professor Kari Alitalo. “He has expertise and interest in many aspects of what iCAN aims to do and success in leading complex projects”.
Mäkelä joins iCAN April 1 from his current position as director of
“iCAN has ambitious goals in research, innovation and impact and the University of Helsinki wants to provide the best possible resources for this. Tomi Mäkelä has excellent experience and is in a key position to reach the goals,” says Vice-Rector of University of Helsinki
Further information:
Professor Tomi Mäkelä, tel. +358 50 528 6128
Academy Professor Kari Alitalo, tel. +358 50 500 3572